Log in to save to my catalogue

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute sympt...

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute sympt...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_746083345

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial

About this item

Full title

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial

Publisher

England: Elsevier Ltd

Journal title

Lancet neurology, 2010-05, Vol.9 (5), p.489-497

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Few randomised clinical trials have investigated the use of antithrombotic drugs for early secondary prevention of stroke or transient ischaemic attack in patients with intracranial atherosclerotic stenosis. Microembolic signals, detected by transcranial doppler, are a surrogate marker of future stroke risk and have been used to...

Alternative Titles

Full title

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_746083345

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_746083345

Other Identifiers

ISSN

1474-4422

E-ISSN

1474-4465

DOI

10.1016/S1474-4422(10)70060-0

How to access this item